Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Zealand Pharma - Filing #1350008

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—		—	—	—	—	—	—	—	—	—	—
Reserve of exchange differences on translation	—	—	22,704,000 DKK	—	—	—	14,617,000 DKK	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	—	—	200,205,000 DKK	—	—	—	223,454,000 DKK	—	—	—	—	—
Current assets	—	—	1,779,788,000 DKK	—	—	—	1,316,352,000 DKK	—	—	—	—	—
Non-current liabilities	—	—	102,575,000 DKK	—	—	—	528,404,000 DKK	—	—	—	—	—
Current liabilities	—	—	284,579,000 DKK	—	—	—	195,491,000 DKK	—	—	—	—	—
Revenue	—	342,788,000 DKK	—	—	—	—	—	—	103,986,000 DKK	—	—	—
Profit (loss) from continuing operations	—	703,739,000 DKK	—	—	—	—	—	—	965,610,000 DKK	—	—	—
Profit (loss) from discontinued operations	—	- DKK	—	—	—	—	—	—	236,525,000 DKK	—	—	—
Profit (loss)	- DKK	703,739,000 DKK	—	703,739,000 DKK	- DKK	- DKK	—	- DKK	1,202,135,000 DKK	- DKK	1,202,135,000 DKK	- DKK
Other comprehensive income	- DKK	8,087,000 DKK	—	- DKK	- DKK	8,087,000 DKK	—	- DKK	462,000 DKK	- DKK	- DKK	462,000 DKK
Comprehensive income	—	695,652,000 DKK	—	—	—	—	—	—	1,201,673,000 DKK	—	—	—